As COVID cases rise again, what do I need to know about the new FLiRT variants?

We’ve now been living with COVID for well over four years. Although there’s still much to learn about SARS-CoV-2 (the virus that causes COVID) at least one thing seems clear: it’s here to stay.

Powered by WPeMatico

Aktis Oncology partners Eli Lilly to discover, develop anticancer radiopharmaceuticals

Boston: Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, has announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform.

The collaboration draws on Aktis’ proprietary radiopharmaceutical platform together with Lilly’s expertise in oncology drug development and commercialization, with the goal of developing first- in-class and differentiated therapeutics for a range of solid tumors.

“Our strategic collaboration with Lilly leverages Aktis’ unique miniprotein radiopharmaceutical platform capabilities to address novel targets, while delivering a safe and effective clinical profile,” said Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology. “We are pleased to partner with Lilly in efforts to increase the number of patients that can derive meaningful clinical benefit from targeted radiopharmaceuticals.”

Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be eligible to receive up to an additional $1.1 billion in potential preclinical, clinical, regulatory and commercial milestones, as well as tiered royalties.

In exchange, Lilly will receive worldwide rights to develop radiopharmaceutical therapeutic and diagnostic products discovered by Aktis on a defined set of targets selected by Lilly.

“This collaboration with Aktis Oncology builds upon our growing radiopharmaceutical capabilities and provides access to an exciting and innovative technology for creating important and differentiated radiopharmaceuticals. We look forward to collaborating with Aktis and utilizing this emerging modality to bring forward meaningful new therapies for people with cancer,” said Jacob Van Naarden, President, Lilly Oncology.

Read also: Alonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and Compliance Officer: Eli Lilly

Powered by WPeMatico

ICMR Calls For Research Proposals for 2024-2025, All Details Here

New Delhi- Through a notice, the Indian Council of Medical Research (ICMR)  has called for research proposals for the year 2024-2025. The online research proposals are invited from the eligible applicants from UGC-recognised universities, research institutions/medical/dental colleges/Institutes of National Importance.

The Applications can be submitted online through the web portal of DHR, which is mentioned in the notice.

The research proposals are called for the following programs-

S.NO

COMPONENT OF THE SCHEME

DEADLINE

1

Short-Term Studentship (STS).

30th June 2024

2

MD/MS/DM/MCh/DNB/DrNB/MDS thesis support.

1st June 2024 to 30th June 2024

3

Short-term National Fellowship.

30th June 2024

4

Long-Term National Fellowship.

30th June 2024

5

Women Scientist fellowship.

30th June 2024

6

Biomedical research grant for NRI/OCI/PIO.

30th June 2024

7

Support to Institutes for Training/Modules/Courses in biomedical research.

30th June 2024

8

International Travel Grant Support For Non-DHR/ICMR Scientists & Researchers.

Applications are invited on a rolling basis.

9

Workshops funding grants in biomedical research.

Applications are invited on a rolling basis.

10

Start-up grant for fellows undergone long-term/short-term training supported by DHR.

30th June 2024

COMPONENTS OF THE SCHEME

I. Short-Term Studentship (STS)

II. MD/MS/DM/MCh/DNB/DrNB/MDS Thesis Support

III. MBBS/MD/MS-Ph.D. Program

IV. Non-medical fellowships for Ph.D.-NET (BRET)

V. Short-term Fellowship Abroad

VI. Long-term Fellowship Abroad 3

VII. Short-term Fellowship at Indian Institutes

VIII. Long-term Fellowship at Indian Institutes

IX. Women Scientist fellowship

X. Biomedical research grant for NRI/OCI/PIO

XI. Fellowship for best achievement in biomedical research

XII. International Travel Grant for non-DHR/ICMR scientists & researchers

XIII. Workshops funding grant in biomedical research

XIV. Support to Institutions and Scientific Professionals/Bodies/Associations

XV. Start-up Grant.

The Human Resource Development (HRD) Scheme aims to provide opportunities for advanced training in biomedical and health research to create a pool of trained & experienced human resources in India.

To view the notice, click the link below

Powered by WPeMatico

BOPEE Invites Online Applications For 12th-Based Paramedical Diploma Admissions 2024, Details

Jammu & Kashmir- The J&K Board of Professional Entrance Examinations has invited online application forms from the eligible/desirous candidates who intend to appear in the Common Entrance Test (CET) for admission to 12th based Paramedical Diploma ( such as X-ray tech, Dental Astt., ECG tech, Med/Pharma Astt., Lab Astt. etc) including Medical record Tech. (MRT) Courses for the Academic Session-2024 in the Government / Private Colleges / Institutions of the UT of J&K.

The date for the CET for admission to the 12th-based Paramedical Diploma will be notified later. The examination will be conducted offline simultaneously at Jammu and Srinagar centres as may be decided by the Board. Meanwhile, information regarding availability, venue and timing of online admit cards for the Common Entrance Test will be released separately in due course.

In regard to this, the J&K Board has released a notice detailing the eligibility, submission of application forms, registration fees and other details.

FEES

Applications for the said examination are available and will remain valid till 8th June 2024 (Midnight). While submitting online applications candidates have to pay Rs. 1000/- online through Credit Card/Debit Card/Net Banking.

SUBMISSION OF ONLINE APPLICATION FORMS

The interested candidates are required to upload the following scanned Original / self-attested Certificates in the PDF format with sizes from 100-200 KB along with the Application Form-

i Domicile of UT of J&K/UT of Ladakh as the case may be (For Candidates of UT of Ladakh, ST certificate issued by the Competent Authority of Ladakh shall be treated as Domicile Certificate).

ii Qualifying marks (12th Class) certificate; (where result is declared).

iii Date of Birth Certificate (only Matriculation Certificate issued by the Board).

iv Valid Reserved Category Certificate, if any.

v Any other documents, as required.

However, it is for the information of all the concerned that afore titled documents as required for submission of the online application form shall be considered provisional and subject to change(s), if any, as may be notified by the Competent Authority.

DOCUMENTS

i Marks certificate of the qualifying examinations (12th class marks certificate).

ii Date of birth (Matriculation / Secondary School Certificate only) from a recognized Board.

iii Domicile Certificate for candidates belonging to UT of J&K and ST certificate as a Domicile for candidates belonging to UT of Ladakh.

iv Category Certificate, if any.

v Any other document as may be required by the Institution.

ELIGIBILITY

A. 12th BASED PARAMEDICAL DIPLOMAS COURSE

a A candidate must-

i be a domicile of UT of J&K/UT of Ladakh as the case may be (For Candidates belonging to UT of Ladakh, ST certificate issued by Competent authority of Ladakh shall be treated as Domicile certificate).

ii not have crossed 35 years of age as on 01-01-2024.

iii have passed 10+2 or equivalent examination from a recognized Board with PCB/PCM and English securing minimum aggregate 40% marks for Open Merit Candidates and 35% marks for Reserved Category candidates.

iv have passed 10+2 with English having 40% marks in Vocational ANM course from Schools recognized by INC/Vocational stream in Health Care Science from a recognized CBSE Board/Centre.

v be a Registered ANM with pass marks.

vi be medically fit.

b. The candidates appearing/appeared in 10+2 (12th Class) examination 2024 can also apply, provided such candidates have to qualify 12th class examination on or before the date of declaration of the result of the Common Entrance Test / or on or before the date of counseling as may be notified by the Board, otherwise their candidature shall be cancelled ab-initio.

B MEDICAL RECORD TECH. (MRT) COURSE (IN SKIMS ONLY)

A candidate must-

(i) be a domicile of UT of J&K/UT of Ladakh as the case may be( For Candidates belonging to UT of Ladakh, ST certificate issued by a Competent Authority of Ladakh shall be treated as a Domicile certificate).

ii be 17 years old and not more than 28 years of age as on 31-12-2024.

iii have passed 10+2 or equivalent examination from a recognized Board in any stream securing a minimum of 50% marks for Open Merit & 40 % marks under the Reserved category.

iv be medically fit.

b. The candidates appearing/appeared in the 10+2 (12th Class) examination 2024 can also apply, provided such candidates have to qualify the 12th class examination on or before the time of declaration of the result of the Common Entrance Test / or on or before the date of counselling as may be notified by the Board, otherwise their candidature shall be cancelled.

The notice also states that the Board shall not be responsible for any act of Page 2 of 6 omissions or commission in filling up of the Online Application Form by the candidate(s). J&K Board further advised the candidates to remain in touch with the BOPEE website. The Board does not take any responsibility for delays in the publication of notices and notifications in the print media. If so, such publications are not under the control of the Board, notwithstanding the Board notifying it on its official website and forwarding the said notifications/notices etc. for publication in newspapers simultaneously on the date of publication.

The applicants can also contact the Help Desk of the I.T. Section of the BOPEE during office hours and on working days only and or email for any assistance and guidance, the notice stated.

To view the notice, click the link below

Powered by WPeMatico

Torrent Pharma reports 56.45 percent jump in net profit to Rs 449 crore in Q4

New Delhi: Torrent Pharmaceuticals Ltd witnessed a significant surge in its consolidated net profit, soaring by 56.45% to reach Rs 449 crore in the March quarter, buoyed by increased revenue. This marks a notable increase from the consolidated net profit of Rs 287 crore reported during the corresponding period of the previous fiscal year, as stated by Torrent Pharmaceuticals in a regulatory filing.

Consolidated revenue from operations in the fourth quarter of FY24 stood at Rs 2,745 crore as against Rs 2,491 crore in the year-ago period, it added.
India revenue was at Rs 1,380 crore, up 10 per cent while the same for Brazil was at Rs 372 crore, registering a growth of 17 per cent, and Germany was at Rs 280 crore, up 11 per cent in the quarter, the company said.
On the other hand, US business revenue was at Rs 262 crore, down 6 per cent, it added.
Total expenses in the quarter under review was higher at Rs 2,145 crore as compared to Rs 2,067 crore in the same period a year ago.
Torrent Pharma said its board has recommended a final dividend of Rs 6 per equity share of Rs 5 each, subject to shareholders’ approval.
Further, the board has also recommended obtaining an enabling approval from the shareholder to raise up to Rs 5,000 crore through issuance of equity shares, including convertible bonds/debentures through qualified institutional placement (QIP) and or any other modes, PTI reported
For the fiscal ended March 31, 2024 consolidated net profit was at Rs 1,656 crore as compared to Rs 1,245 crore in the previous year, the company said.
Consolidated revenue from operations in FY24 stood at Rs 10,728 crore as compared to Rs 9,620 crore in FY23.

Powered by WPeMatico

77-year-old Zambian man with triple cancers gets new lease of life at Jaslok Hospital

Mumbai: Jaslok Hospital and Research Centre in Mumbai recently treated Mr George, a 77-year-old gentleman from Zambia, who was presented with symptoms of rectal bleeding and constipation. 

Prior to this had undergone a surgery for benign prostatic hyperplasia in 2015, which revealed prostatic malignancy. Due to the complexity of his case, involving multiple overlapping issues, he was referred to Jaslok Hospital for comprehensive management. At Jaslok Prompt evaluation revealed a growth in his large intestine that was diagnosed as a cancer of the sigmoid colon.

During a metastatic workup he was found to have high-grade metabolic activity with circumferential wall thickening in the sigmoid colon, moderately increased metabolic activity in a pericolonic lymph node, and metastasis in a solitary pulmonary nodule in the left upper lung.

Also Read:193 kg US man undergoes total knee replacement at Jaslok Hospital

Additionally, an enlarged prostate with extensive osteosclerotic skeletal lesions indicative of metastasis were observed. Low-grade metabolic activity was noted in the right lobe of the thyroid too. PSMA PET confirmed the thyroid lesion to be a secondary deposit.

At Jaslok Hospital, a multidisciplinary team comprising gastrointestinal surgeons, head and neck cancer surgeons, medical oncologists, urologists, and a nuclear medicine specialist evaluated Mr George. The central question revolved around whether aggressive treatment of the colon cancer in the presence of advanced prostate cancer would benefit him or not? Imaging studies, including a PET scan revealed localised sigmoid colon tumor, localised thyroid cancer and prostate cancer with extensive bone metastasis.

On Prostate-specific Membrane Antigen (PSMA) scan for prostate cancer indicated potential responsiveness to Lu-PSMA radiation therapy despite of extensive bony metastasis with good long term survival. At length on discussion in an Institutional Tumour Board comprising of Dr Shailesh Raina, Director Urology, Dr Mehul Bhansali, Director Surgical Oncology, Dr Vikram Lele, Director Nuclear Medicine, Dr Pravin Agrawal, Sr Consultant GI & HPB Surgery, Dr Vivek Shetty, Consultant GI & HPB Surgery, Dr Ganapathy Bhatt, Consultant Medical Oncology, Dr Rahul Chhabria, Consultant Cardiology and Dr Savi Kapila, Consultant Anaesthesiology a comprehensive plan was devised. It was surgical intervention for Colon cancer and Thyroid Cancer followed by Lutetium PSMA Radiation therapy for Prostate cancer.

On January 6, 2024, Mr. George underwent two major surgeries simultaneously under single anaesthesia monitored by Dr Savi Kapila. A right hemithyroidectomy was performed by Dr Mehul Bhansali, Director Surgical Oncology and Dr Snehal Bhange, Consultant General Surgery, followed by a laparoscopy-assisted sigmoid colectomy by Dr Pravin Agrawal, Senior GI & HPB Surgeon and Dr Vivek Shetty GI & HPB Surgeon.

Despite the lengthy duration of approximately 7 to 8 hours surgery, he demonstrated remarkable tolerance to the procedures. Subsequent to surgery, he was closely monitored in the ICU for any signs of complications. He was mobilized and started on solid diets as per the protocol.

Dr Mehul Bhansali, Director Surgical Oncology opined that “since the patient had a guarded prognosis in view of the extensive skeletal metastasis and lung metastasis from the primary prostatic malignancy as well as a second sigmoid malignancy a consensus decision was taken not to subject the patient for second neck surgery for a completion thyroidectomy. The final histopathology after the hemi thyroidectomy revealed low grade follicular thyroid carcinoma, minimally invasive type.”

Speaking about George, Dr Vikram Lele, Director Nuclear Medicine at Jaslok Hospital said “This patient had 3 malignancies: Of the colon, thyroid and prostate at the same time. PET CT scans with different isotopes helped to characterize these 3 malignancies and map out their spread in the body and to decide which malignancy had spread .

Treatment was also given for the metastatic prostate cancer with Nuclear medicine isotope 177Lu- PSMA. The thyroid cancer will be treated with radioactive Iodine later. Nuclear medicine is thus playing the major part in diagnosis and therapy of this patient”

GI & HPB Surgeons Dr Pravin Agraval & Dr Vivek Shetty said, “Between all three malignancies survival of colon cancer is lesser without treatment followed by Thyroid cancer followed by Prostate cancer. Hence he was subjected to aggressive surgical treatment for colon cancer and thyroid cancer”. George Namakando, was overwhelmed with his treatment and mentioned” I have survived this only because of the complete team of well-experienced doctors at Jaslok Hospital.

They always kept my family updated about every minute detail. I am grateful to all the doctors and nurses who looked after me like a family”. Dr. Milind Khadke, Director at Jaslok Hospital & Research Centre, emphasized the significance of adopting a multidisciplinary approach in managing complex cases like Mr. George’s. “Our team of physicians and surgeons collaborated seamlessly, pooling their expertise to formulate a meticulously tailored treatment strategy. This commitment to synergy and comprehensive care underscores our unwavering dedication to meeting the diverse needs of our patients.”

The patient’s departure from the hospital occurred under stable conditions, marking an important milestone in his treatment journey as he prepared to continue his comprehensive care regimen.

Powered by WPeMatico

No Ban on Electro-Homeopathy but Practitioners Can’t Use ‘Doctor’ Prefix: Allahabad HC

Allahabad: In a recent judgment, the Allahabad High Court bench clarified that even though Electro Homeopathy is not banned in Uttar Pradesh, such practitioners of electro-homoeopathy cannot use the ‘doctor’ prefix before their names.

Addressing the issue of Electro Homeopathy practice, the HC bench comprising Justices Vivek Chaudhary and Om Prakash Shukla noted that the practice will be governed by the Government order issued on 25.11.2003.

“Having traced the relevant orders and clarifications issued by the Central Government, State Government as well as the Supreme Court from time to time, this Court arrives at an inescapable conclusion that although no institution can confer a diploma or degree in Electro Homeopathy, however, as there is no ban, the petitioners can always practice Electro Homeopathy as an alternative therapy within the parameters of order dated 25.11.2003. This Court also finds that in the absence of any statutory provisions, there could not be any conferring of diploma or degrees in Electropathy or Electro Homeopathy in India, however, there is no bar in issuance of Certificate for the said study,” the Court mentioned in the order.

This observation was made by the HC bench while considering a plea by the Electro Homeopathy practitioners, seeking permission to practice in Uttar Pradesh.

While considering the plea, the bench held 

“…the petitioners can practice Electro Homeopathy so long as it is not banned by any competent authority. They, however, cannot use the prefix “Doctor” before their name.”

The petitioners obtained a Certificate from the Count Mattei Association to practice Electro Homeopathy System of Medicines. According to the petitioners, by virtue of the said certificate, they are allowed to practice Electro Homeopathy System of medicine in Punjab, Delhi, Maharashtra, West Bengal, Kerala and other states. However, they claimed that with the said certificate, they were not permitted to practice in Electro Homeopathy System of Medicine in Uttar Pradesh as till date UP has not made any law in this regard.

Approaching the HC bench, they prayed for a direction for non-interference by the authorities and the consequential relief of permitting them to practice Electro Homoeopathy system of alternate Medicine in Uttar Pradesh till the competent authorities frame the rules in that regard.

They also prayed for quashing the order/circular dated 25.11.2003 issued by the Union Government and the Government Order dated 01.06.2004 issued by the State of Uttar Pradesh. Through the order dated 25.11.2003, the Union Government had clarified that Electropathy/Electro Homeopathy System of medicines were not recommended as an alternative system of medicines. It had also directed the institutes under the State/ Union Territories not to grant any degree/diploma in the various unrecognized streams of alternative medicines including Electro Homeopathy System of medicines.

Referring to the Government Order dated 21.06.2011, the petitioners’ counsel argued that the order dated 25.11.2003 and order dated 05.05.2010 were instructions relating to practice, education and research for alternative system of medicine like Electropathy, Electro-Homeopathy etc. The counsel argued that as per the order dated 21.06.2011, there was no legal impediment in imparting education as long as no degree-diploma was awarded/issued for that course and that the Electro Homeopathy practitioners were not allowed to use the prefix ‘doctor’ before their name.

The petitioners’ counsel also relied on the memorandum dated 13.04.2023 by the State Government, which said that the right to make rules and regulations for Electropathy was vested in the Central Government and if the Central Government made rules/regulations regarding this, the State would follow the same. It further mentioned that the State Government was not authorized to make/enforce rules/regulations regarding the practice, education, development and promotion of electro-homeopathy. 

While considering the matter, the HC bench noted, “the right to make Rules and Regulations for practice for Electropathy including Electro Homeopathy is vested with the Central Government.”

Further, the Court noted that the Central Government had not established any council for recognising the Electro Homeopathy system of medicine in the country and only various orders were issued by the Central Government in this regard from time to time.

Regarding the Government Order dated 25.11.2003, the Court observed that “Electropathy/Electro Homeopathy System of medicines was not recommended as an alternative system of medicines and all the State/Union territory Governments were directed to give wide publicity to the said decision of the Government of India and would also ensure that the institutions under the State/ Union Territories do not grant any degree/diploma in the various unrecognized streams of alternative medicines including Electro Homeopathy System of medicines, which have not been recommended for recognition and the term ‘Doctor’ can be used by the practitioners of the recognized system of medicines.” However, the Court noted that they did not put any restriction on practising the said alternate method of treatment.

The High Court also observed that through the order dated 05.05.2010, the Union Health Ministry, Department of Health Research, Government of India clarified that “there is no proposal to stop persons like the petitioners from practising in Electropathy or imparting education” as long as it was done within the provision of the order dated 25.11.2003.

Further, the bench observed that following the Allahabad High Court’s order in the case of Electro Homeo Medical Association of India Vs. State of U.P. & others, the Central Government considered the representation submitted by the Secretary of Electro Homeo Medical Association of India, Lucknow and issued an order dated 21.06.2011, clarifying that the Ministry of Health and Family Welfare order dated 25.11.2003 and the order dated 05.05.2010 would be treated as instructions of the Government of India, related to the practice of education and research concerning alternative system of medicines like Electropathy, Electro Homeoopathy etc. 

The Court also referred to the Supreme Court order in the case of Sutapa Singh Vs. State of U.P. and others, where the Apex Court allowed the appellant to provide alternative therapy i.e. Electro Homeopathy as there was no ban by any competent authority. Back then, the Supreme Court had clarified that the practice of electropathy or imparting education should be done within the provisions and parameters of the order dated 25.11.2003 issued by the Central Government.

Relying on these judgments, orders and clarifications issued by the Central and State Government and the Supreme Court, the High Court bench concluded that although no institution can confer a diploma or degree in Electro Homeopathy, as there was no ban, the petitioners could always practice Electro Homeopathy as an alternative therapy within the parameters of the order dated 25.11.2003.

“This Court also finds that in the absence of any statutory provisions, there could not be any conferring of diploma or degrees in Electropathy or Electro Homeopathy in India, however, there is no bar in issuance of Certificate for the said study,” observed the Court.

“In view of the aforesaid, it is held that the petitioners can practice Electro Homeopathy so long as it is not banned by any competent authority. They, however, cannot use the prefix “Doctor” before their name. Accordingly, a direction for noninterference by the respondents/authorities concerned and consequential relief of permitting the petitioners to practice Electro Homeopathy system of medicine in the State of Uttar Pradesh, till the rules in that regard is framed by the competent authority, is also issued,” it further mentioned in the order. 

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/allahabad-hc-electro-homeopathy-238990.pdf

Also Read: Clampdown on fake medical courses: Health Officials Seal Fake Medical College at Olapalayam for offering courses without recognition

Powered by WPeMatico

Summer Internship Programme 2024: MUHS Releases Revised List of Selected Candidates For Allotted Centres, Details

Maharashtra- Maharashtra University of Health Sciences (MUHS) has published the revised list of selected applicants for admissions to be made at the “Summer Internship Programme” (SIP) Centres conducting the programme for the academic year 2024.

In this regard, by an official circular, strict instructions have been given to the concerned applicants that the last date of joining at the respective allotted SIP centres should be made on or before 30th May 2024.

REVISED LIST

As per the revised list, there are a total of 73 SIP centres wherein out of a total of 803 seats intake, 74 seats are vacant.

S.NO

SIP CENTRE

TOTAL INTAKE

VACANT INTAKE

1

NATIONAL INSTITUTE OF PUBLIC HEALTH TRAINING & RESEARCH, MUMBAI

12

0

2

HAFFKINE INSTITUTE FOR TRAINING, RESEARCH & TESTING, MUMBAI

20

0

3

B.K.L.WALAWALKAR RURAL MEDICAL COLLEGE, DIST- RATNAGIRI MAHARASHTRA

20

12

4

SHRADDHA REHABILITATION FOUNDATION, KARJAT, RAIGAD

4

0

5

GOVERNMENT HOMEOPATHIC HOSPITAL, VILE PARLE MUMBAI

8

0

6

ORTHOVED HOSPITAL, THANE

4

0

7

VRT MADHAVBAG INSTITUTE OF PREVENTIVE CARDIOLOGY, THANE

10

0

8

IIT BOMBAY (BIOMEDICAL ENGINEERING AND TECHNOLOGY INNOVATION CENTRE), MUMBAI

5

0

9

CENTRAL AYURVEDA RESEARCH INSTITUTE, MUMBAI (CCRAS, MINISTRY OF AYUSH, GOVT. OF INDIA

10

0

10

KASTURBA HEALTH SOCIETY’S MEDICAL RESEARCH CENTRE (KHS-MRC), MUMBAI

10

0

11

IIT BOMBAY, KOITA CENTRE FOR DIGITAL HEALTH, MUMBAI

4

0

12

MAHATMA GANDHI MISSION’S DENTAL COLLEGE & HOSPITAL NAVI MUMBAI

10

0

13

P. D. HINDUJA NATIONAL HOSPITAL & MEDICAL RESEARCH CENTRE, MUMBAI

8

0

14

ENTRE OF EXCELLENCE IN RESEARCH & TRAINING IN INFECTIOUS DISEASES, MUHS, REGIONAL CENTRE MUMBAI

10

0

15

DR. KULKARNI’S AAROGYADHAM, THANE

20

0

16

ENCODE, MUMBAI

4

0

17

DR. BABASAHEB AMBEDKAR TECHNOLOGICAL UNIVERSITY, LONERE

0

0

18

NATIONAL INSTITUTE OF NATUROPATHY (NIN), PUNE

40

0

19

RASAYANI BIOLOGICS PVT LTD PUNE

6

3

20

KANKAYAN AYURVED CHIKITSALAYA KOLHAPUR

4

0

21

PUNYASHLOK AHILYADEVI HOLKAR SOLAPUR UNIVERSITY SOLAPUR

10

5

22

MAEER’S VISHWARAJ INSTITUTE OF NURSING, PUNE

50

0

23

ICMR- NATIONAL INSTITUTE OF TRANSLATIONAL VIROLOGY & AIDS RESEARCH PUNE

5

0

24

VAIDYARAJ DATAR PANCHABHAUTIK CHIKITSA AND SAMSHODHAN KENDRA, SANGLI

12

0

25

PRACHIN SANHITA GURUKUL, PUNE

10

0

26

VIGNAHAR MEDICAL FOUNDATION, NARAYANGAON, PUNE

10

0

27

BHARAT VIKAS SHIKSHAN SANSTHA, PUNE

10

0

28

PERSISTENT SYSTEMS LTD, PUNE

2

0

29

NATIONAL CENTER FOR CELL SCIENCES, PUNE

3

0

30

MAEER MIT PUNE’S MIMER MEDICAL COLLEGE & BSTR HOSPITAL, PUNE

38

0

31

AFMC, PUNE

12

0

32

HON.SHRI.ANNASAHEB DANGE AYURVED MEDICAL COLLEGE, POST GRADUATE & RESEARCH CENTRE, ASHTA, SANGALI

40

0

33

COLLEGE OF NURSING, AFMC, PUNE

8

0

34

BRACT’s VISHWAKARMA INSTITUTE OF INFORMATION TECHNOLOGY

10

5

35

MUHS REGIONAL CENTRE, PUNE

8

0

36

GENETIC HEALTH & RESEARCH CENTRE, NASHIK

2

0

37

DHANVANTARI AYURVED SHIKSHAN SANSHODHAN SANSTHA, DHULE

2

0

38

MUHS, MPGI – MAHARASHTRA POST-GRADUATE INSTITUTE OF MEDICAL EDUCATION & RESEARCH, NASHIK

4

0

39

MUHS, AYUSH DEPARTMENT, NASHIK

12

0

40

MUHS, INSTITUTE OF MEDICAL EDUCATION TECHNOLOGY AND TEACHERS TRAINING, NASHIK

8

0

41

SATTAVAM AYURVEDA PANCHAKARMA CENTER AND NEURO SPINE REHAB CENTRE, NASHIK

10

0

42

SNEHALAYA, CFHRC, AHMEDNAGAR

6

0

43

NETRAYU AYURVEDIC HOSPITAL, JALGAON

6

0

44

NAMCO HOSPITAL, NASHIK

63

0

45

AUSHADHI BHAVAN, NASHIK

12

0

46

OMAX DENTAL CARE CLINIC, DHULE

4

0

47

SRI ADI YOGA INTERNATIONAL INSTITUTE FOR LEARNING & RESEARCH, NASHIK

10

20

48

KBCNMU CENTRE FOR INNOVATION, INCUBATION & LINKAGES, @KBCNMU, JALGAON

5

0

49

DR. BABASAHEB AMBEDKAR VAIDYAKIYA PRATISHTAN AURANGABAD

8

1

50

JEEVAN REKHA ANALYTICAL SERVICES, AURANGABAD

25

0

51

MUHS REGIONAL CENTRE, AURANGABAD

4

0

52

CHHATRAPATI SHAHU MAHARAJ SHIKSHAN SANSTHAN’S DENTAL COLLEGE & HOSPITAL, CHHATRAPATI SAMBHAJINAGAR

10

0

53

SANE GURUJI RUGNALAY & RESEARCH CENTER, KINWAT

12

4

54

NATIONAL CANCER INSTITUE NAGPUR

4

0

55

VISVESVARAYA NATIONAL INSTITUTE OF TECHNOLOGY UNIVERSITY VNIT NAGPUR, MAHARASHTRA

8

0

56

HEATCO, OSTEOPOROSIS AWARENESS CAMPAIGN PROGRAMME IN RURAL AREA. THROUGH: CHAUDHARY HOSPITAL, NAGPUR

4

0

57

SAMKA AYURVED, DEVI SAMKA MAHILA BAHU SANSTHA, YAVATMAL

4

0

58

SUYASH HOSPITAL, AMRAVATI

4

0

59

CSIR-NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUE, (NEERI) NAGPUR

2

0

60

GONDWANA UNIVERSITY, GADCHIROLI

10

0

61

LOK BIRADARI PRAKALP HOSPITAL, GADCHIROLI

4

0

62

GOVERNMENT AYURVED COLLEGE, NAGPUR

10

0

63

SMT. K. B. ABAD HOMOEOPATHIC MEDICAL COLLEGE, CHANDWAD

5

5

64

ASHOKA MEDICOVER HOSPITAL, NASHIK

12

4

65

SWARGIYA DADASAHEB KALMEGH SMRUTI DENTAL COLLEGE & HOSPITAL,NAGPUR

5

0

66

VSPM MADHURIBAI DESHMUKH INSTITUTE OF NURSING EDUCATION, NAGPUR

4

0

67

MUHS REGIONAL CENTRE, NAGPUR

8

0

68

LNCT UNIVERSITY, BHOPAL, MADHYA PRADESH ( LN AYURVED COLLEGE & HOSPITAL BHOPAL)

25

11

69

MAHATMA GANDHI INSTITUTE OF HEALTH INFORMATICS MGUMST, JAIPUR RAJASTHAN

9

3

70

CENTRE FOR DNA FINGERPRINTING & DIAGNOSTICS, (CDFD) HYDERABAD

6

0

71

NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS, KALYANI, WEST BENGAL

3

1

72

ALL INDIA INSTITUTE OF AYURVEDA (AIIA)

30

0

73

DR. VITHALRAO VIKHE PATIL FOUNDATION’S MEDICAL COLLEGE & HOSPITAL AHMEDNAGAR

6

0

To view the list, click the link below

It is pertinent to note that, the merit list is prepared on the basis of marks or scores obtained by the candidate as per the marking criteria of 13 marks (marks obtained out of 03 marks of objective + marks obtained out of 10 marks prescribed for 12th / HSC percentage ≤ 13 marks). Seats will be allotted to the candidates on the basis of inter-se merit. However, there will be a tie where marks obtained by the applicant in 12th/HSC will be considered and given preference in the merit list. Further, if the tie still persists, marks obtained by the applicant in 10th/SSC will be considered and given preference in the merit list. Apart from this, candidates with higher age will also be given preference in the merit list.

Moreover, considering the feedback and responses from the previous year, MUHS has also decided that the allocation of students will also be done on a pro-rata basis keeping in view the number of applications received from each faculty, so as to give adequate representation to the students of each faculty.

Further, it is to be noted that no written/email communication will be entertained in this regard and also no written communication will be made by the University to the applicant(s) or any SIP Centre.

Therefore, for any updates and information, it will be the duty of the concerned applicant and enrolled SIP Centre to regularly visit the University website and check for the details.

It is clarified that the students who have participated in the said scheme last year and have again submitted their applications to the University this year will be considered for allotment if there are vacancies. Meanwhile, the fresh candidates who have not had any opportunity to participate in the SIP programme will be given the first priority in the allotment.

All concerned applicants are requested to note this and take necessary action at their level, the circular added.

To view the notice, click the link below

Powered by WPeMatico

KGMU to Host ‘Scientific Program on Robotic Surgery’ On May 29, Details

Lucknow- King George’s Medical University (KGMU) has informed through a circular that the University is going to organise a “Scientific Program on Robotic Surgery” on Wednesday, May 29, 2024, at 3:00 PM at Brown Hall, Admin Block, KGMU, Lucknow.

As per the circular, Prof. Ashutosh Tiwari, MD, Chairman, Milton and Carrol Petrie Department of Urology at Medicine Mount Sinai, New York, USA will deliver a Guest Lecture on the topic “Journey of a Surgeon Scientist Through Neural Pathways, Genomic Complexity, Cancer Immunology and 10,000 Robotic Prostatectomies”.

Besides, Dr Amit Agarwal, Former Head of the Department of Endocrine Surgery, SGPGIMS, Lucknow, Dr Rajendra Prasad, Department of Surgery, AIIMS, New Delhi and Dr. Anupma Bahadur, Department of Obst. & Gynae, AIIMS, Rishikesh will also deliver lectures.

The Program details are as follows

S.NO

TIMINGS

EVENTS

1

3:00 PM – 3:05 PM

Welcome: Setting the Agenda: Prof. AA Sonkar, Head, Department of Surgery, KGMU.

2

3:05 PM – 03:10 PM

Conception of the Program by Prof Soniya Nityanand, Vice Chancellor, KGMU.

3

03:10 PM – 03:15 PM

Introduction of the Speakers: Prof Apul Goel, Head, Department of Urology, KGMU.

4

03:15 PM – 03:30 PM

Lecture by Prof Amit Agarwal, Former Head, Department of Endocrine Surgery, SGPGIMS, Lucknow

Topic: How to Establish Robotic Surgery Program in a Government Institute: SGPGIMS experience.

5

03:30 PM – 03:45 PM

Lecture by Dr. Rajendra Prasad, Department of Surgery, AIIMS, New Delhi

Topic: Current Status of Robotics in General Surgery.

6

03:45 PM – 04:00 PM

Lecture by Dr. Anupma Bahadur, Department of Obst. & Gynae, AIIMS, Rishikesh

Topic: Robotics in Gynaecology: AIIMS Experience

7

04:00 PM – 04:30 PM

Guest Lecture by Dr Ashutosh Tewari, MD, Chairman, Milton and Carroll Petrie Department of Urology at Medicine Mount Sinai, New York, USA

Topic: Journey of a Surgeon Scientist Through Neural Pathways, Genomic Complexity, Cancer Immunology and 10,000 Robotic Prostatectomies.

The programme will conclude with presenting mementoes to all the speakers and a vote of thanks by Professor Anju Agarwal.

Through the circular, all HODs and faculty members including all the residents of their department who are available and not involved in emergency services are required to attend the lecture. HODs are also requested to disseminate the information amongst the residents of their department.

To view the circular, click the link below

Powered by WPeMatico

Research suggests HPV vaccines prevent cancer in men as well as women

New research highlights the significant impact of the HPV vaccine in preventing cancer in both men and women, although fewer boys than girls are getting vaccinated in the United States. Originally developed to prevent cervical cancer in women, the HPV vaccine is now showing promising results in reducing HPV-related cancers in men.
The study compared 3.4 million vaccinated and unvaccinated individuals and found that vaccinated men had a lower risk of developing cancers of the anus, penis, mouth, and throat. Specifically, there were 57 HPV-related cancers among unvaccinated men compared to 26 in vaccinated men.

Powered by WPeMatico